The low number of clinical trials in Africa and biomedical datasets that disproportionately represent populations of European ancestry contribute to the suboptimal efficacy and safety of some ...
Ozlem Tastan Bishop receives funding from 1. Alliance for Accelerating Excellence in Science in Africa (AESA) and African Academy of Sciences (AAS): COVID-19 Research and Development Goals For Africa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback